Background {#s1}
==========

Mitochondrial respiratory chain (MRC), consisting of five enzymatic complexes embedded in the inner mitochondrial membrane, has an important role in providing cells with ATP. Mutations in the nuclear or mitochondrial DNA affecting MRC could result in a wide array of disorders with various neurological and non-neurological presentations ([@B1]). Complex III, consisting of 11 subunits, is responsible for the transfer of electrons from reduced coenzyme Q to cytochrome C and thus, contributes to the formation of electrochemical potential ultimately leading to the production of ATP ([@B2]).

Mitochondrial complex III deficiency, nuclear type 2 (OMIM: 615157) is an autosomal-recessive disorder caused by mutations in *TTC19* gene. *TTC19* (Entrez Gene: 54902; OMIM: 613814) is involved in the preservation of complex III function by allowing turnover of Rieske protein through removal of the N-terminal proteolytic fragment of the protein ([@B3]). Mutations in *TTC19* have been shown to be linked with rapidly progressive neurological impairment ([@B2]), spinocerebellar ataxia ([@B4]--[@B6]), progressive psychosis ([@B4]), Leigh syndrome ([@B7]), developmental delay and regression in childhood ([@B2], [@B8]--[@B10]), bilateral cherry red spots, and failure to thrive ([@B10]). Clinical, neuroimaging, and biochemical findings in patients with pathogenic mutations in *TTC19* gene are summarized in [Table 1](#T1){ref-type="table"}.

###### 

Clinical, neuroimaging, and biochemical findings in patients with *TTC19* mutations.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **References**                      **Ghezzi**\                                                                  **Nogueira**\                         **Atwal ([@B7])**                        **Morino**\                   **Melchionda**\                                                                                                                                                            **Kunii**\                                                                     **Mordaunt**\                                                             **Koch**\                                                                                                                                            **Conboy**\                                                                                                                      **The present study**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                      **et al**. **(**[@B2]**)**                                                   **et al**. **(**[@B4]**)**                                                     **et al. ([@B5])**            **et al. ([@B8])**                                                                                                                                                         **et al. ([@B6])**                                                             **et al. ([@B10])**                                                       **et al**. **(**[@B9]**)**                                                                                                                           **et al. ([@B11])**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  ----------------------------------- ---------------------------------------------------------------------------- ------------------------------------- ---------------------------------------- ----------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------- ------------------------------------- ----------------------------------------------------- ---------------------------------------
  **Sex**                             F                                                                            M                                     F                                        M                             M                                                                                                                                                                          M                                                                              M                                                                         F                                                                                                                                                    M                                                                                                                                F                                                                                                                                                   F                                                                                               M                                                                                                                                 F                                                                                                                     M                                                                                                                       M                                                                                                             M                                                                                                          F                                     M                                                     M

  **Age at onset**                    5 years                                                                      10 years                              5 years                                  43 years                      27 years                                                                                                                                                                   12 years                                                                       15 years                                                                  34 years                                                                                                                                             1 year                                                                                                                           31 years                                                                                                                                            18 months                                                                                       25 years                                                                                                                          8 years                                                                                                               Neonatal                                                                                                                19 months                                                                                                     3 years                                                                                                    6 years                               3.5 years                                             7 years

  **Origin**                          Italian                                                                      Italian                               Italian                                  Italian                       Portuguese                                                                                                                                                                 Portuguese                                                                     Portuguese                                                                Portuguese                                                                                                                                           Hispanic                                                                                                                         Japanese                                                                                                                                            Arab                                                                                            Japanese                                                                                                                          Iraqi                                                                                                                 Turkish                                                                                                                 Austrian                                                                                                      Romanian                                                                                                   Romanian                              Kuwaiti                                               Iranian

  **Presenting signs and symptoms**   Learning disability\                                                         Learning disability and gait ataxia   Regression of language and gait ataxia   Weakness of all extremities   Mood disorder and gait ataxia                                                                                                                                              Compulsive\                                                                    Aggressive behavior                                                       Aggressive behavior                                                                                                                                  Developmental delay and language regression                                                                                      Dysarthria                                                                                                                                          Unsteady gait with frequent\                                                                    Mood disorder and gait ataxia                                                                                                     Developmental delay                                                                                                   Lactic acidosis                                                                                                         Global developmental delay, ataxia, dysarthria, hypotonia                                                     Developmental delay, ataxia, regression, hypotonia                                                         Mild developmental delay, hypotonia   Recurrent stroke-like episodes, developmental delay   Aggressive behavior and hyperactivity
                                      and gait ataxia                                                                                                                                                                                                                                                                                                                                                      lying                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              falls                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  **Elevated lactate (Blood/CSF)**    NA                                                                           NA                                    NA                                       NA                            NA                                                                                                                                                                         NA                                                                             NA                                                                        NA                                                                                                                                                   NA                                                                                                                               +/NA                                                                                                                                                --/NA                                                                                           --/--                                                                                                                             --/--                                                                                                                 +/NA                                                                                                                    +/NA                                                                                                          --/--                                                                                                      NA                                    NA                                                    +/NA

  **Neurological findings**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Cognitive impairment                NA                                                                           \+                                    NA                                       NA                            \+                                                                                                                                                                         \+                                                                             \+                                                                        \+                                                                                                                                                   NA                                                                                                                               \+                                                                                                                                                  \+                                                                                              \+                                                                                                                                \+                                                                                                                    \+                                                                                                                      NA                                                                                                            NA                                                                                                         NA                                    \+                                                    \+

  Behavioral disorder                 NA                                                                           NA                                    NA                                       NA                            \+                                                                                                                                                                         \+                                                                             \+                                                                        \+                                                                                                                                                   NA                                                                                                                               NA                                                                                                                                                  \+                                                                                              \+                                                                                                                                \+                                                                                                                    NA                                                                                                                      NA                                                                                                            NA                                                                                                         --                                    NA                                                    \+

  Ataxia                              \+                                                                           \+                                    \+                                       \+                            \+                                                                                                                                                                         \+                                                                             \+                                                                        \+                                                                                                                                                   NA                                                                                                                               \+                                                                                                                                                  \+                                                                                              \+                                                                                                                                \+                                                                                                                    \+                                                                                                                      \+                                                                                                            \+                                                                                                         --                                    \+                                                    \+

  Dysphagia                           \+                                                                           \+                                    NA                                       NA                            \+                                                                                                                                                                         \+                                                                             \+                                                                        \+                                                                                                                                                   NA                                                                                                                               NA                                                                                                                                                  NA                                                                                              NA                                                                                                                                \+                                                                                                                    \+                                                                                                                      \+                                                                                                            \+                                                                                                         --                                    \+                                                    \+

  Dysarthria                          \+                                                                           \+                                    \+                                       \+                            \+                                                                                                                                                                         \+                                                                             \+                                                                        \+                                                                                                                                                   NA                                                                                                                               \+                                                                                                                                                  \+                                                                                              \+                                                                                                                                --                                                                                                                    \+                                                                                                                      \+                                                                                                            \+                                                                                                         --                                    \+                                                    \+

  Spasticity                          NA                                                                           NA                                    NA                                       \+                            \+                                                                                                                                                                         \+                                                                             \+                                                                        NA                                                                                                                                                   NA                                                                                                                               NA                                                                                                                                                  NA                                                                                              \+                                                                                                                                --                                                                                                                    \+                                                                                                                      \+                                                                                                            \+                                                                                                         --                                    NA                                                    \+

  Epilepsy                            NA                                                                           NA                                    NA                                       NA                            NA                                                                                                                                                                         NA                                                                             NA                                                                        NA                                                                                                                                                   NA                                                                                                                               NA                                                                                                                                                  NA                                                                                              NA                                                                                                                                --                                                                                                                    \+                                                                                                                      \+                                                                                                            \+                                                                                                         --                                    NA                                                    --

  Hyperactive deep tendon reflexes    \+                                                                           NA                                    NA                                       NA                            \+                                                                                                                                                                         \+                                                                             \+                                                                        \+                                                                                                                                                   NA                                                                                                                               \+                                                                                                                                                  --                                                                                              \+                                                                                                                                --                                                                                                                    \+                                                                                                                      \+                                                                                                            \+                                                                                                         \+                                    NA                                                    \+

  **Neuroimaging features**           Leukoencephalopathy, hyper-intense caudate nucleus, and cerebellar atrophy   NA                                    Cerebellar atrophy                       NA                            Olivo-ponto-cerebellar atrophy and hypersignal changes in caudate, putamen, cerebellar dentate nucleus, medial midbrain, and medullary olives on T~2~-weighted sequences   Progressing T~2~ high signal lesions in putamen, caudate body, and brainstem   Cerebellar atrophy and bilateral T~2~ high intensity at inferior olives   Mild cerebellar vermis atrophy and bilateral symmetrical T~2~ high intensity lesions in lentiform nucleus with cavitated aspects on FLAIR sequence   Cerebellar atrophy and symmetric T~2~ high intensity lesions in the inferior olives and adjacent to periaqueductal gray matter   Mild cerebellar and cerebral volume loss, bilateral patchy high signal T~2~/FLAIR, and hypo- to iso-intense T~1~ foci within the lentiform nuclei   Symmetrical T~2~-weighted hyper-intensities of basal ganglia and periventricular white matter   Bilateral T~2~-weighted hyper-intensities of the putamen, the caudate nucleus, and the mesencephalon periaqueductal gray matter   Hyper-intensities of nucleus lenticularis and nucleus caudatus, loss of volume in the putamen, and cerebral atrophy   Hyper-intensities in caput caudate nucleus and basal parts of the putamen, increased interfoliar spaces in cerebellum   Bilateral symmetrical T~2~-weighted hyper-intensities and cystic changes of putamina and the caudate nuclei   Bilateral hypersignal changes in caudate bodies and lentiform nuclei on T2 and FLAIR, cerebellar atrophy                                                                                               
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Herein, we report on a 15-year-old boy presenting with psychiatric symptoms, progressive ataxia, spastic paraparesis, bilious vomiting, and constipation with a novel homozygous frameshift mutation in *TTC19*.

Case Presentation {#s2}
=================

The patient is a 15-year-old boy, who is the first and only child of consanguineous healthy parents who were first cousins. He initially presented at the age of 7 years with psychiatric symptoms including aggressive behavior and hyperactivity for which he was under treatment with methylphenidate (Ritalin), risperidone, olanzapine, and biperiden. The patient had normal psychomotor development until the age of 13 years, when he began to develop speech difficulty. Between the age of 13 and 14, he started to experience gait disturbance and difficulty walking, which progressed in the following year and made the patient wheelchair-bound. On physical examination, the patient was emaciated and cachectic; weighing 45 kg with a height of 165 cm, his body mass index (BMI) was 16.5 kg/m^2^. Neurological examination was significant for bilateral hyperactive deep tendon reflexes, severe ataxia, tremor, horizontal nystagmus, and spasticity, which was more pronounced in the lower extremities. The patient made limited eye contact and appeared to have intellectual impairment. In addition, musculoskeletal examination was notable for *pes cavus*.

Laboratory results including serum electrolytes, plasma ammonia, liver function test, blood amino-acid analysis, and cerebrospinal fluid examination were all normal. However, his blood lactate level was elevated to 27 mg/dL (reference range: 4.5--19.8 mg/dL). Magnetic resonance imaging (MRI) of the brain showed hypersignal changes bilaterally in caudate bodies and lentiform nuclei on T~2~ and fluid attenuated inversion recovery imaging (FLAIR). The lesions appeared as hypodensities in computed tomography (CT). In addition, cerebellar atrophy was detected ([Figure 1](#F1){ref-type="fig"}).

![Brain MRI. **(A)** Axial FLAIR image of the patient showing hyper-signal changes bilaterally in caudate bodies and lentiform nuclei. **(B)** Coronal T~2~ image showing cerebellar atrophy.](fneur-10-00944-g0001){#F1}

The patient\'s condition deteriorated significantly in subsequent months, leading to severe cognitive impairment and mutism. In addition, the patient developed dysphagia, bilious vomiting, and constipation. Upper endoscopy revealed erythematous lesions distributed in the entire esophagus. Furthermore, gastric mucosa in the fundus, body, and antrum was hyperemic with multiple erosions. These lesions were also seen in the bulb and the second part of duodenum. A percutaneous endoscopic gastrostomy (PEG) tube was inserted due to feeding problems.

Total genomic DNA was extracted from the patient\'s blood sample using QIAamp DNA Blood Mini kit (Qiagen, Germany). Subsequently, whole-exome sequencing (WES) was performed using Illumina NextSeq500 instrument. Variants with an allele frequency of more than 0.005 in gnomAD, EXAC, and our in-house database were excluded. In addition, synonymous and non-coding variants were filtered. Subsequently, considering the autosomal-recessive pattern of inheritance, homozygous, and compound heterozygous variants were analyzed ([Table S1](#SM1){ref-type="supplementary-material"}). Finally, correlation of the patient\'s clinical findings with phenotypes associated with the genes harboring identified genetic variations revealed that our patient was homozygous for a previously undescribed frameshift deletion mutation in *TTC19* gene (NM_017775.3: c.581delG: p.Arg194Asnfs^\*^16). This novel mutation along with other previously reported pathogenic variants are represented in [Figure 2](#F2){ref-type="fig"}. Sanger sequencing of exon six of the gene was also performed in the patient and his parents, using the following forward (5′-ATTCACAGTTGGCTCATCACTC-3′) and reverse (5′-AGATGTTGTGTGCCCCACTA-3′) primers. It was confirmed that both parents were heterozygous for the mutation, and that the proband was homozygous for this mutation ([Figure 3](#F3){ref-type="fig"}).

![Schematic representation of *TTC19* gene (GenBank accession no. [NM_017775.3](NM_017775.3)). The blue boxes indicate exons. Novel (shown in red) and previously reported mutations are shown.](fneur-10-00944-g0002){#F2}

![Sequence chromatograms of **(A,B)** parents and **(C)** the patient. The arrow indicates the site of the causative mutation.](fneur-10-00944-g0003){#F3}

Written informed consent was obtained from the patient\'s parents. This study was conducted in accordance with ethical standards of the declaration of Helsinki.

Discussion and Conclusion {#s3}
=========================

Mitochondrial disorders are clinically and genetically heterogeneous, greatly hindering the diagnosis of these disorders. Recent advances made in genetic technologies, allowing sequencing and in-depth investigation of the genome, has substantially improved the diagnosis of mitochondrial diseases. Autosomal-recessive cerebellar ataxias (ARCA) are a diverse group of neurodegenerative disorders characterized by movement incoordination and unsteadiness ([@B12]). A growing number of defects in biological pathways such as deficiency of DNA repair, defects in lipoprotein assembly, chaperone dysfunction, and mitochondrial defects can lead to ARCA ([@B12]). However, in almost half of the patients the genetic cause remains elusive ([@B13]). Herein, we reported a mitochondrial ARCA in a 15-year-old patient who presented with progressive ataxia, spastic paraparesis, psychiatric, and gastrointestinal symptoms with a novel frameshift deletion in *TTC19* gene. Protein-protein interaction analysis revealed an interaction of *TTC19* with many genes, including *ZFYVE26*, which has been identified as the cause of autosomal-recessive spastic paraplegia 15 ([@B14], [@B15]). Furthermore, animal models have highlighted the importance of *TTC19* gene. TTC19-null adult *Drosophilia melanogaster* exhibited reduced lifespan, low fertility, adult-onset motor impairment, and abnormal optomotor function ([@B2]).

The neurological and psychiatric manifestations of the patient described here coincides well with the manifestations reported earlier; progressive signs and symptoms of basal ganglia and cerebellar dysfunction such as ataxia, dysarthria, and spasticity were observed. Furthermore, psychiatric manifestations are often seen in dominant types of cerebellar ataxia, such as spinocerebellar ataxia 7 and 8; they are generally uncommon in those with ARCA ([@B16], [@B17]). However, it seems that patients with mutations in *TTC19* gene are more likely to present psychiatric manifestations, as described in our patient ([@B4], [@B6]).

Patients with mitochondrial disorders are frequently reported to have gastrointestinal symptoms. These symptoms might be the predominant presentation in disorders like mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), whereas in other disorders like Leigh syndrome, gastrointestinal symptoms are usually less prominent compared with neurological presentations ([@B18]). Despite the fact that dysphagia is reported in previous reports, constipation and bilious vomiting have not hitherto been reported in the literature. This might be due to intestinal pseudo-obstruction, which has also been reported in other mitochondrial disorders ([@B19], [@B20]).

Advanced genetic sequencing technologies developed in recent years, such as WES, have not only facilitated identification of novel disease genes, but also allowed revelations about novel phenotypes associated with mutations in the genes already linked with other clinical features. Our findings expanded the clinical features of *TTC19* mutation to potentially include gastrointestinal involvement. Further functional studies are however needed to shed light over the underlying pathophysiological mechanisms.
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